Bladder stromal tumor of uncertain malignant potential arising in ectopic prostatic tissue: Case report with MRI–pathology correlation Authors: Ignacio Alfredo Maldonado Schoijet, Giancarlo Schiappacasse Faúndes, Andres Labra Weitzler, Katerin Retamales Rojas, Javier Contreras Ebner Published: 2026 ABSTRACT Stromal tumor of uncertain malignant potential (STUMP) is a rare mesenchymal neoplasm of the prostate with variable biological behavior and limited radiologic characterization. Most reported cases arise within the prostate gland. Ectopic prostatic tissue, defined as histologically confirmed prostate tissue outside the gland, is uncommon and most frequently identified in the bladder trigone, bladder neck, or urethra.We report the case of a 74 year-old man with a history of transurethral resection of the prostate who underwent prostate MRI due to elevated prostate-specific antigen levels. Imaging incidentally revealed a well-defined submucosal trigonal bladder nodule showing mild T2 hyperintensity, restricted diffusion, and avid early enhancement. Initial cystoscopic biopsy suggested ectopic prostatic tissue. Over a 4-year follow-up, the lesion demonstrated interval growth and the patient developed lower urinary tract symptoms and hematuria.Transurethral en bloc resection revealed a spindle cell stromal proliferation with mild atypia. Immunohistochemistry showed positivity for CD34, desmin, and progesterone receptors, consistent with STUMP arising in ectopic prostatic tissue.This case expands the radiologic spectrum of STUMP and highlights the importance of MRI and cystoscopic correlation in the evaluation of atypical bladder submucosal lesions. Introduction Prostatic stromal tumors account for less than 1% of all prostate neoplasms and include stromal sarcoma and stromal tumor of uncertain malignant potential (STUMP). STUMP was first described by Gaudin et al. [1] in 1998 based on distinctive histologic and immunohistochemical features that differentiate it from prostatic stromal sarcoma [2]. Although considered neoplastic, STUMP exhibits a broad spectrum of biological behavior, ranging from indolent lesions to locally aggressive tumors, with potential for local recurrence and rare progression to stromal sarcoma [[3], [4], [5]]. Imaging descriptions of STUMP are limited. On multiparametric magnetic resonance imaging, these tumors most commonly appear as well-defined masses that may be solid or partially cystic, with heterogeneous signal intensity on T2-weighted images and variable enhancement patterns following contrast administration [[6], [7], [8]]. Ectopic prostatic tissue is defined as histologically confirmed prostate tissue located outside the gland. It is an uncommon finding, most frequently reported in the bladder trigone, bladder neck, and prostatic urethra [[9], [10], [11]]. Several theories have been proposed to explain its origin, including persistence of embryologic remnants, aberrant migration of prostatic tissue during development, or metaplastic transformation associated with chronic inflammation [12]. Although typically benign, ectopic prostatic tissue has been associated with hyperplasia and, rarely, malignant transformation into adenocarcinoma. Large series have shown that ectopic prostatic tissue within the bladder can clinically and radiologically mimic urothelial carcinoma, posing a diagnostic challenge [16]. The purpose of this report is to describe the magnetic resonance imaging features and pathologic correlation of a stromal tumor of uncertain malignant potential arising in ectopic prostatic tissue of the bladder, an entity that has not been previously reported, and to discuss its differential diagnosis among submucosal bladder masses. Case report A 74 year old man with a history of transurethral resection of the prostate (TURP) performed in 2012 for benign prostatic hyperplasia was referred for prostate magnetic resonance imaging due to an elevated prostate specific antigen (PSA) level of 7.3 ng/mL. At the time of presentation, the patient was asymptomatic, with no lower urinary tract symptoms, hematuria, or urinary tract infections. Laboratory tests, including renal function and urinalysis, were unremarkable apart from the PSA elevation. Multiparametric prostate MRI was performed, including T2-weighted imaging, diffusion weighted imaging with apparent diffusion coefficient (ADC) maps, and dynamic contrast enhanced sequences. In addition to residual transition zone hyperplasia, MRI incidentally revealed a well-defined 12-mm submucosal nodule located at the bladder trigone. The lesion demonstrated mild hyperintensity on T2 weighted images, isointensity on T1 weighted images, restricted diffusion, and avid early enhancement compared with the adjacent bladder wall. Based on these findings, the lesion was initially reported as a vesical nodule classified as VI-RADS 3. No extravesical extension, pelvic lymphadenopathy, or invasion of adjacent structures was identified. Cystoscopy showed an approximately 1 cm subepithelial lesion at the bladder trigone. Targeted biopsy was performed, and histologic analysis was consistent with ectopic prostatic tissue. Given the benign diagnosis and absence of symptoms, conservative management with imaging surveillance was elected. Four years later, the patient developed progressive lower urinary tract symptoms accompanied by gross hematuria. Follow up multiparametric MRI demonstrated interval growth of the trigonal lesion, which now measured 17 mm in maximal diameter (Fig. 1). The lesion maintained imaging characteristics similar to those observed on the baseline study, including mild T2 hyperintensity, isointense signal on T1 weighted images, restricted diffusion with low ADC values of approximately 1.1 × 10⁻³ mm²/s, and avid early enhancement on dynamic contrast-enhanced images without delayed washout. The lesion was described as subepithelial, and the differential diagnosis on imaging included paraganglioma versus a tumor of mesenchymal origin. There were no imaging signs of necrosis, extravesical invasion, or regional lymphadenopathy. The lesion remained well circumscribed and produced a mild mass effect on the bladder lumen.Fig. 1Incidental bladder trigonal lesion on prostate MRI. Baseline axial T2-weighted image shows a 12-mm, well-defined, mildly hyperintense submucosal nodule at the bladder trigone (not shown). (A, B) Follow-up coronal and sagittal T2-weighted images demonstrate interval growth to 17 mm with mild hyperintensity. (C) The lesion shows restricted diffusion with corresponding low ADC (1.1 × 10⁻³ mm²/s). (D) Dynamic contrast-enhanced axial images show avid early enhancement without washout.Fig 1 dummy alt text Incidental bladder trigonal lesion on prostate MRI. Baseline axial T2-weighted image shows a 12-mm, well-defined, mildly hyperintense submucosal nodule at the bladder trigone (not shown). (A, B) Follow-up coronal and sagittal T2-weighted images demonstrate interval growth to 17 mm with mild hyperintensity. (C) The lesion shows restricted diffusion with corresponding low ADC (1.1 × 10⁻³ mm²/s). (D) Dynamic contrast-enhanced axial images show avid early enhancement without washout. Repeat cystoscopy demonstrated a submucosal trigonal mass protruding into the bladder lumen (Fig. 2). Given interval growth and the development of symptoms, transurethral en bloc resection was performed. Histopathologic examination revealed a spindle cell stromal proliferation composed of mildly atypical cells arranged in fascicles, interspersed with collagen bundles and scattered small lymphocytes, without significant mitotic activity or necrosis. Immunohistochemical analysis demonstrated positivity for CD34, desmin, and progesterone receptors, with negative staining for smooth muscle actin, STAT6, and ALK, findings consistent with a stromal tumor of uncertain malignant potential arising in ectopic prostatic tissue (Fig. 3).Fig. 2Cystocopic view of the bladder trigone. Endoscopic examination shosws a smooth, submucosal mass protruding into the trigonal lumen (arrow).Fig 2 dummy alt textFig. 3Histologic sections. (A, B) Spindle-cell proliferation with high cellularity and areas of myxoid stroma. Tumor cells show mild atypia, without mitosis or necrosis. (C) Immunohistochemistry shows strong nuclear positivity for progesterone receptors (D) and cytoplasmic positivity for desmin. Overall, the findings are consistent with stromal tumor of uncertain malignant potential (STUMP).Fig 3 dummy alt text Cystocopic view of the bladder trigone. Endoscopic examination shosws a smooth, submucosal mass protruding into the trigonal lumen (arrow). Histologic sections. (A, B) Spindle-cell proliferation with high cellularity and areas of myxoid stroma. Tumor cells show mild atypia, without mitosis or necrosis. (C) Immunohistochemistry shows strong nuclear positivity for progesterone receptors (D) and cytoplasmic positivity for desmin. Overall, the findings are consistent with stromal tumor of uncertain malignant potential (STUMP). Surgical margins were negative, indicating complete resection. Postoperative management consisted of imaging surveillance. At 4 months follow up, the patient remained asymptomatic, and follow up MRI showed no evidence of local recurrence. Discussion Prostatic stromal tumors are rare mesenchymal neoplasms of the prostate, divided into STUMP and prostatic stromal sarcoma (PSS), accounting for less than 1% of prostatic tumors [2]. Gaudin et al. [1] first described STUMP in 1998 as a distinct entity with histologic and immunohistochemical features that differentiate it from sarcoma [3]. Although considered neoplastic, STUMP exhibits highly variable clinical behavior. Most cases follow an indolent course, but local recurrence is common, and rare cases of transformation into PSS have been reported [4,5]. Reports of STUMP radiological findings are limited, and the described spectrum is broad. Many cases present as large multilocular cystic or mixed cystic–solid lesions with thickened septa and enhancing solid components [[6], [7], [8]]. These can resemble prostatic cystadenoma, mucinous adenocarcinoma, or sarcoma, especially when cystic degeneration or necrosis occurs [9]. Solid variants have also been described, showing low to intermediate signal on T1 weighted images, heterogeneous high signal on T2 weighted images, moderate diffusion restriction with apparent diffusion coefficient values around 1.1 × 10⁻³ mm ²/s, and gradual or persistent enhancement on dynamic sequences [6,10]. The presence of a T2 hypointense pseudocapsule has also been reported [7]. In the present case, the lesion demonstrated mild T2 hyperintensity, restricted diffusion with low ADC values, and avid early enhancement, features that overlap with previously reported solid variants of STUMP despite its ectopic location. Ectopic prostatic tissue is defined as histologically confirmed prostate tissue located outside the gland. It is most frequently found in the bladder trigone, bladder neck, and prostatic regions of the urethra. However, it has also been described in the seminal vesicles, testis, retroperitoneum, and even in the spleen and female genitourinary tract [[11], [12]]. Several mechanisms have been proposed, including persistence of embryologic remnants, misplacement of prostatic tissue during organogenesis, migration of prostatic stem cells, and metaplastic transformation of urothelium in the setting of chronic inflammation [14]. Ectopic prostatic tissue has been associated with hyperplasia and, rarely, adenocarcinoma. Rare cases of adenocarcinoma arising in ectopic prostate tissue within the bladder trigone or dome have been reported, confirmed by immunohistochemistry for prostate specific markers such as PSA, which distinguish them from urothelial carcinoma or metastases [12]. To our knowledge, a stromal tumor of uncertain malignant potential arising from ectopic prostatic tissue in the bladder has not been previously reported, making this case a novel contribution to the literature. When evaluating a bladder submucosal lesion, the primary differential diagnosis includes non-epithelial tumors (Table 1). Bladder leiomyoma is the most common benign type, usually appearing as a well-defined, T2-hypointense submucosal nodule with homogeneous enhancement and no diffusion restriction [9]. Inflammatory myofibroblastic tumor typically arises in the anterior wall or dome and appears as a smooth, T2-hyperintense lesion with strong, progressive or ring-like enhancement, often without necrosis [9]. Bladder paraganglioma is rare but should be suspected when a submucosal mass shows marked T2 hyperintensity, avid enhancement, and restricted diffusion; catecholamine related symptoms during urination may provide a clinical hint [9]. Hemangiomas, though uncommon, often display very high T2 signal and hypervascularity, and are essential to recognize because of the risk of significant bleeding during biopsy or removal [9]. Other rare lesions, such as solitary fibrous tumor, inflammatory pseudotumor variants, lipoma, neurofibroma, and rhabdomyosarcoma in children, can also mimic submucosal masses. The imaging features observed in the present case, particularly restricted diffusion, avid early enhancement, and interval growth, favored a neoplastic process but were not specific enough to establish a definitive diagnosis, underscoring the importance of cystoscopic and histopathologic correlation.Table 1Key multiparametric MRI features for the differential diagnosis of submucosal bladder lesions.Table 1 dummy alt textEntityT2-weighted signalT1-weighted signalDiffusion-weighted imagingEnhancement patternKey distinguishing featuresSTUMPHeterogeneous, usually intermediate to mildly hyperintenseLow to intermediateRestricted diffusion; ADC commonly ∼ 1.0-1.2 × 10⁻³ mm²/sGradual, persistent, or progressive enhancement; may be early avidUsually well defined; may show pseudocapsule; variable biological behavior; recurrence possibleLeiomyomaLow signal intensityLow to intermediateTypically no diffusion restrictionHomogeneous, gradual enhancementMost common benign mesenchymal bladder tumor; smooth margins; lacks diffusion restrictionParagangliomaMarkedly hyperintenseLow to intermediateRestricted diffusionAvid early enhancementHypervascular lesion; may be associated with catecholamine related symptoms during micturitionInflammatory myofibroblastic tumorIntermediate to high signalLow to intermediateVariable; often no marked restrictionProgressive or ring-like enhancementOften located in anterior wall or dome; inflammatory background; may mimic malignancy Table 1Key multiparametric MRI features for the differential diagnosis of submucosal bladder lesions.Table 1 dummy alt textEntityT2-weighted signalT1-weighted signalDiffusion-weighted imagingEnhancement patternKey distinguishing featuresSTUMPHeterogeneous, usually intermediate to mildly hyperintenseLow to intermediateRestricted diffusion; ADC commonly ∼ 1.0-1.2 × 10⁻³ mm²/sGradual, persistent, or progressive enhancement; may be early avidUsually well defined; may show pseudocapsule; variable biological behavior; recurrence possibleLeiomyomaLow signal intensityLow to intermediateTypically no diffusion restrictionHomogeneous, gradual enhancementMost common benign mesenchymal bladder tumor; smooth margins; lacks diffusion restrictionParagangliomaMarkedly hyperintenseLow to intermediateRestricted diffusionAvid early enhancementHypervascular lesion; may be associated with catecholamine related symptoms during micturitionInflammatory myofibroblastic tumorIntermediate to high signalLow to intermediateVariable; often no marked restrictionProgressive or ring-like enhancementOften located in anterior wall or dome; inflammatory background; may mimic malignancy Key multiparametric MRI features for the differential diagnosis of submucosal bladder lesions. Histopathologic examination was essential for definitive diagnosis. The lesion showed a spindle-cell stromal proliferation with mild atypia and absence of necrosis or significant mitotic activity. Immunohistochemical positivity for CD34 and desmin supported a stromal origin, while progesterone receptor positivity is a characteristic feature of prostatic stromal tumors and is helpful in distinguishing STUMP from other spindle-cell lesions such as leiomyoma and inflammatory myofibroblastic tumor [4]. Negative staining for smooth muscle actin, STAT6, and ALK further excluded alternative mesenchymal neoplasms. Management of stromal tumors of uncertain malignant potential is not standardized and depends on tumor location, clinical presentation, and completeness of surgical resection [3,5]. Complete surgical excision is generally recommended when feasible, given the well documented risk of local recurrence and the rare possibility of malignant transformation into stromal sarcoma [3,5]. Reported recurrence rates vary widely in the literature, and recurrence may occur even after apparently complete resection, underscoring the need for long term follow up. In the present case, transurethral en bloc resection achieved negative margins. Given the known recurrence risk associated with STUMP, postoperative surveillance with imaging was recommended. Although no consensus exists regarding optimal surveillance intervals, periodic follow up with MRI and/or cystoscopic evaluation is considered prudent, particularly in cases with atypical location or interval growth. Conclusion This case describes a stromal tumor of uncertain malignant potential arising in ectopic prostatic tissue of the bladder, an exceedingly rare and previously unreported entity. The multiparametric MRI findings demonstrated a well-defined submucosal trigonal lesion with restricted diffusion and avid early enhancement, imaging features that overlap with other non-epithelial bladder tumors and can lead to diagnostic uncertainty. This report highlights the importance of recognizing ectopic prostatic tissue as a potential origin of unusual bladder tumors and emphasizes the complementary roles of MRI, cystoscopy, and histopathologic analysis in establishing an accurate diagnosis. Given the potential for recurrence, long term imaging surveillance is recommended following complete resection. Patient consent Written informed consent was obtained from the patient for publication of this case report and any accompanying images.